Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-035930
Filing Date
2025-03-10
Accepted
2025-03-10 08:09:19
Documents
5
Effectiveness Date
2025-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 prld-20250310.htm S-8 133830
2 EX-5.1 prld-ex5_1.htm EX-5.1 12003
3 EX-23.2 prld-ex23_2.htm EX-23.2 3681
4 EX-FILING FEES prld-exfiling_fees.htm EX-FILING FEES 27825
5 GRAPHIC img162401780_0.jpg GRAPHIC 20384
  Complete submission text file 0000950170-25-035930.txt   206690
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285662 | Film No.: 25722219
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)